Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, August 3rd. Analysts expect Allscripts Healthcare Solutions to post earnings of $0.15 per share for the quarter.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, May 4th. The software maker reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01. The business had revenue of $415 million during the quarter, compared to the consensus estimate of $415.20 million. Allscripts Healthcare Solutions had a negative net margin of 2.93% and a positive return on equity of 5.75%. The company’s revenue was up 20.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 EPS. On average, analysts expect Allscripts Healthcare Solutions to post $0.62 EPS for the current fiscal year and $0.71 EPS for the next fiscal year.

Allscripts Healthcare Solutions, Inc. (NASDAQ MDRX) opened at 12.51 on Thursday. The firm’s market capitalization is $2.27 billion. The stock has a 50 day moving average of $12.43 and a 200-day moving average of $12.09. Allscripts Healthcare Solutions, Inc. has a one year low of $9.80 and a one year high of $15.17.

In related news, President Richard J. Poulton sold 25,000 shares of the stock in a transaction on Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total value of $301,500.00. Following the completion of the transaction, the president now owns 412,488 shares in the company, valued at approximately $4,974,605.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.75% of the company’s stock.

Several brokerages recently issued reports on MDRX. Piper Jaffray Companies restated a “hold” rating and set a $14.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Friday, July 21st. Bank of America Corporation began coverage on Allscripts Healthcare Solutions in a research note on Monday, May 15th. They issued a “neutral” rating and a $14.00 target price on the stock. BidaskClub upgraded Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research note on Tuesday, June 13th. Maxim Group reiterated a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research note on Friday, May 5th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $13.00 target price on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $14.74.

COPYRIGHT VIOLATION NOTICE: This piece was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/07/27/allscripts-healthcare-solutions-inc-nasdaqmdrx-scheduled-to-post-earnings-on-thursday.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.